AI assistant
LIGAND PHARMACEUTICALS INC — Director's Dealing 2021
Feb 5, 2021
31289_dirs_2021-02-05_4aafa87f-72b0-43c4-a2b7-4eeef0d6fb9f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2021-02-03
Reporting Person: FOEHR MATTHEW W (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-03 | Common Stock | A | 6595 | $0.0 | Acquired | 167198 | Direct |
| 2021-02-04 | Common Stock | M | 1000 | $74.42 | Acquired | 168198 | Direct |
| 2021-02-04 | Common Stock | M | 44547 | $21.92 | Acquired | 212745 | Direct |
| 2021-02-04 | Common Stock | S | 44547 | $176.86 | Disposed | 168198 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-04 | Employee Stock Option (right to buy) | $21.92 | M | 44547 | Disposed | 2023-02-15 | Common Stock (44547) | Direct |
| 2021-02-04 | Employee Stock Option (right to buy) | $74.42 | M | 1000 | Disposed | 2024-02-12 | Common Stock (1000) | Direct |
| 2021-02-03 | Employee Stock Option (right to buy) | $177.5 | A | 13136 | Acquired | 2031-02-03 | Common Stock (13136) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.52 to $180.89, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13.
F3: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/12/14.
F4: Grant to reporting person of options to purchase shares of common stock ("Option Shares"), exerciseable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/03/2021.